Caribou Biosciences, Inc

67 articles with Caribou Biosciences, Inc

• 

  Broad Institute Fends off CRISPR Patent Lawsuit, at Least for Now

  9/11/2018

  It was a win for the Broad Institute of the Massachusetts Institute of Technology (MIT) and Harvard University, as a federal court of appeals ruled against the University of California (UC) on CRISPR patents.
• 

  CRISPR Pioneer Jennifer Doudna Opens Lab at Bay Area’s Gladstone Institutes

  9/7/2018

  CRISPR pioneer Jennifer Doudna has set up shop in San Francisco’s Gladstone Institutes. Doudna, a UC Berkley professor credited with the co-discovery of CRISPR-Cas9 genome editing technique, will focus on the development of new ways to implement the gene-editing technique for disease treatment.
• 

  Antiva Biosciences: Case Study in Difficulties Facing Biotechs Focused on Women’s Health

  8/17/2018

  In the biotech world, only 7 to 9 percent of companies have women as their chief executives. Antiva BioSciences is a good example of how this problem is perpetuated.
• 

  10 Women Biotech CEOs Lead the Charge

  6/26/2018

  The general consensus is that only about seven to nine percent of chief executive roles in biotech are filled by women. As low as that sounds, it’s better than in the Fortune 500, where only about 4.2 percent are led by female chief executives.
• 

  U.S. Grants Emmanuelle Charpentier, U of C and University of Vienna CRISPR Patent

  6/20/2018

  The U.S. Patent and Trademark Office (USPTO) granted Emmanuelle Charpentier, co-founder of ERS Genomics, the University of California and University of Vienna, their first U.S. patent covering the use of CRISPR/Cas9 for gene editing.
• 

  Biotech Companies Continue to Shake Up Leadership with New Appointments

  5/8/2018

  There have been a number of leadership changes in biotech companies over the last week. BioSpace has put together a list of new c-suite level hires and position changes.

• Caribou Biosciences Appoints Timothy F. Herpin, Ph.D. as Chief Business Officer

  5/3/2018

  Caribou Biosciences, Inc. announced today that it has appointed Timothy F. Herpin, Ph.D. as its first Chief Business Officer.

• CRISPR, Intellia, Caribou Biosciences And ERS Genomics Announce Appellate Brief Seeking Reversal Of U.S. Patent Board Decision On CRISPR/Cas9 Gene Editing

  7/26/2017

• Caribou Biosciences Appoints Steven B. Kanner, Ph.D. As Chief Scientific Officer

  7/6/2017

• Caribou Biosciences Announces Grant Of A Key CRISPR-Cas9 Genome Editing Patent In Europe

  5/10/2017

• Caribou Biosciences Announces Grant Of A Key CRISPR-Cas9 Patent In The U.S.

  5/2/2017

• Caribou Biosciences And Dupont Pioneer Develop New Method To Comprehensively Map The Off-Target Activity Of CRISPR-Cas9 Across Entire Genomes

  5/2/2017

• Patent Fight Continues as CRISPR, Intellia, Caribou Biosciences and ERS Genomics Appeal CRISPR Decision

  4/13/2017

• CRISPR, Intellia, Caribou Biosciences And ERS Genomics Provide Update On CRISPR/Cas9 U.S. Patent Interference Proceedings And Grants Of Corresponding Patents In The U.K.

  2/16/2017

• The Jackson Laboratory And Caribou Biosciences Announce CRISPR-Cas9 License Agreement

  10/25/2016

• Caribou Biosciences’ President And CEO Rachel Haurwitz Named To Fortune’s 2016 "40 Under 40" List Of Most Influential Young People In Business

  9/26/2016

• Caribou Biosciences Appoints Vonnie Estes As Group Leader, Agricultural And Industrial Biotechnology

  8/30/2016

• Caribou Biosciences Develops New Method To Profile CRISPR-Cas9 Gene Editing Outcomes

  8/18/2016

• 31-Year-Old Rachel Haurwitz Helms Hot CRISPR-Based Biotech Firm Caribou Biosciences

  6/23/2016

• Genus And Caribou Biosciences Announce Exclusive Collaboration For Leading CRISPR-Cas9 Gene Editing Technology In Livestock Species

  5/18/2016